Login
Companies $JANX
$11.12 +$0.20 (1.83%) After hours
Janux Therapeutics, Inc. logo

Janux Therapeutics, Inc.

januxrx.com

What Do They Do?

Develops immune therapies for cancer patients and people with autoimmune diseases, including treatments that direct immune cells against tumors.

How Do They Make Money?

Janux earns collaboration revenue through upfront payments and research funding; it may receive further payments when development or sales milestones are reached, as well as royalties on sales of licensed products.

FY2025 revenue

Who Are Their Customers?

Janux works with pharmaceutical companies through research collaborations and licenses; Merck holds exclusive worldwide licenses to selected cancer targets.

Do Revenues Turn Into Profits?

No. It lost $113.6M in FY2025.

Operating income, FY2025
−1577% of revenue
▼ −60% (Loss) vs FY2024 (−$98.8M, −934%)
Net income, FY2025
−1136% of revenue
▼ −65% (Loss) vs FY2024 (−$69M, −652%)
Free cash flow, FY2025
−833% of revenue
▼ −89% (Loss) vs FY2024 (−$44.2M, −417%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▼ −7%
vs $10M in Q3 FY2025
Net income
▲ +11% (Loss)
vs −$24.3M in Q3 FY2025

Growing. Revenue grew 2.7x in 4 years, from $3.6M in FY2021 to $10M in FY2025, about 29% a year.

Broader disease focus The latest report describes an immune-modulating program for autoimmune diseases, beyond the older report's cancer-focused TRACTr and TRACIr pipeline.

Who Do They Compete With?

Competes with AbbVie, Amgen, AstraZeneca, Biogen, Bristol Myers Squibb, Gilead, GSK, Johnson & Johnson, Merck &, Lilly, Novartis, Pfizer, Regeneron, Sanofi, Takeda, and Roche/Genentech

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support